Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex - PubMed (original) (raw)
Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
M Tersmette et al. J Virol. 1988 Jun.
Abstract
Human immunodeficiency virus isolates were studied with respect to syncytium-inducing capacity, replicative properties, and host range. Five of 10 isolates from patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex were able to induce syncytia in cultures of peripheral blood mononuclear cells (MNC). In contrast, only 2 of 12 isolates from asymptomatic individuals had syncytium-inducing capacity. Syncytium-inducing isolates were reproducibly obtained from the same MNC sample in over 90% of the cases, independent of the donor MNC used for propagation. Syncytium-inducing capacity was shown to be a stable property of an isolate, independent of viral replication rates. Evidence was obtained that the high replication rate of syncytium-inducing isolates observed during primary isolation may be due to higher infectivity of these isolates. The finding that only syncytium-inducing isolates could be transmitted to the H9 cell line is compatible with this higher infectivity. The frequent isolation of syncytium-inducing isolates from individuals with AIDS-related complex or AIDS and the apparent higher in vitro infectivity of these isolates suggest that syncytium-inducing isolates may unfavorably influence the course of human immunodeficiency virus infection.
Similar articles
- Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, Goudsmit J, Huisman HG, Miedema F. Tersmette M, et al. J Virol. 1989 May;63(5):2118-25. doi: 10.1128/JVI.63.5.2118-2125.1989. J Virol. 1989. PMID: 2564898 Free PMC article. - Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
Schuitemaker H, Kootstra NA, de Goede RE, de Wolf F, Miedema F, Tersmette M. Schuitemaker H, et al. J Virol. 1991 Jan;65(1):356-63. doi: 10.1128/JVI.65.1.356-363.1991. J Virol. 1991. PMID: 1985204 Free PMC article. - Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
Connor RI, Ho DD. Connor RI, et al. J Virol. 1994 Jul;68(7):4400-8. doi: 10.1128/JVI.68.7.4400-4408.1994. J Virol. 1994. PMID: 7515972 Free PMC article. - Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.
Duesberg PH. Duesberg PH. Proc Natl Acad Sci U S A. 1989 Feb;86(3):755-64. doi: 10.1073/pnas.86.3.755. Proc Natl Acad Sci U S A. 1989. PMID: 2644642 Free PMC article. Review. - How does HIV-1 infect a susceptible human cell?: Current thinking.
Al-Jabri AA. Al-Jabri AA. J Sci Res Med Sci. 2003 Aug;5(1-2):31-44. J Sci Res Med Sci. 2003. PMID: 24019733 Free PMC article. Review.
Cited by
- Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties.
Zhou Z, Guo J, Hetrick B, Tiwari S, Haikerwal A, Han Y, Bond VC, Huang MB, Mankowski MK, Snyder BA, Hogan PA, Sharma SK, Liotta DC, Reid TE, Wilson LJ, Wu Y. Zhou Z, et al. PLoS Pathog. 2024 Aug 15;20(8):e1012448. doi: 10.1371/journal.ppat.1012448. eCollection 2024 Aug. PLoS Pathog. 2024. PMID: 39146384 Free PMC article. - The complex nature of CXCR4 mutations in WHIM syndrome.
Rodríguez-Frade JM, González-Granado LI, Santiago CA, Mellado M. Rodríguez-Frade JM, et al. Front Immunol. 2024 Jul 5;15:1406532. doi: 10.3389/fimmu.2024.1406532. eCollection 2024. Front Immunol. 2024. PMID: 39035006 Free PMC article. Review. - New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care.
Hokello J, Tyagi K, Owor RO, Sharma AL, Bhushan A, Daniel R, Tyagi M. Hokello J, et al. Life (Basel). 2024 Jan 9;14(1):104. doi: 10.3390/life14010104. Life (Basel). 2024. PMID: 38255719 Free PMC article. Review. - HIV replication and latency in monocytes and macrophages.
Veenhuis RT, Abreu CM, Shirk EN, Gama L, Clements JE. Veenhuis RT, et al. Semin Immunol. 2021 Jan;51:101472. doi: 10.1016/j.smim.2021.101472. Epub 2021 Feb 27. Semin Immunol. 2021. PMID: 33648815 Free PMC article. Review. - The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases.
García-Cuesta EM, Santiago CA, Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM, Mellado M. García-Cuesta EM, et al. Front Endocrinol (Lausanne). 2019 Aug 27;10:585. doi: 10.3389/fendo.2019.00585. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31507535 Free PMC article. Review.
References
- Science. 1984 May 4;224(4648):497-500 - PubMed
- Br Med J (Clin Res Ed). 1987 Sep 5;295(6598):569-72 - PubMed
- Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 - PubMed
- Eur J Immunol. 1985 Feb;15(2):107-12 - PubMed
- Lancet. 1985 Apr 6;1(8432):815-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical